CA2959621A1 - Selective sampling magnetic resonance-based method for assessing structural spatial frequencies - Google Patents
Selective sampling magnetic resonance-based method for assessing structural spatial frequencies Download PDFInfo
- Publication number
- CA2959621A1 CA2959621A1 CA2959621A CA2959621A CA2959621A1 CA 2959621 A1 CA2959621 A1 CA 2959621A1 CA 2959621 A CA2959621 A CA 2959621A CA 2959621 A CA2959621 A CA 2959621A CA 2959621 A1 CA2959621 A1 CA 2959621A1
- Authority
- CA
- Canada
- Prior art keywords
- value
- gradient
- pulse
- signal
- interest
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 138
- 238000005070 sampling Methods 0.000 title claims description 49
- 230000007170 pathology Effects 0.000 claims abstract description 50
- 230000033001 locomotion Effects 0.000 claims description 81
- 230000005284 excitation Effects 0.000 claims description 21
- 210000000056 organ Anatomy 0.000 claims description 18
- 238000001228 spectrum Methods 0.000 claims description 10
- 210000003484 anatomy Anatomy 0.000 claims description 7
- 230000001629 suppression Effects 0.000 claims description 3
- 230000004075 alteration Effects 0.000 claims 1
- 210000001519 tissue Anatomy 0.000 abstract description 87
- 238000005259 measurement Methods 0.000 abstract description 52
- 201000010099 disease Diseases 0.000 abstract description 33
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 33
- 230000003176 fibrotic effect Effects 0.000 abstract description 19
- 238000003745 diagnosis Methods 0.000 abstract description 15
- 238000001727 in vivo Methods 0.000 abstract description 14
- 206010028980 Neoplasm Diseases 0.000 abstract description 13
- 238000012544 monitoring process Methods 0.000 abstract description 10
- 230000002829 reductive effect Effects 0.000 abstract description 8
- 208000012902 Nervous system disease Diseases 0.000 abstract description 6
- 238000012512 characterization method Methods 0.000 abstract description 6
- 208000020084 Bone disease Diseases 0.000 abstract description 4
- 230000006378 damage Effects 0.000 abstract description 4
- 230000012010 growth Effects 0.000 abstract description 2
- 238000003384 imaging method Methods 0.000 description 39
- 238000002595 magnetic resonance imaging Methods 0.000 description 31
- 238000009792 diffusion process Methods 0.000 description 26
- 210000000988 bone and bone Anatomy 0.000 description 24
- 230000000694 effects Effects 0.000 description 23
- 238000012935 Averaging Methods 0.000 description 21
- 239000000523 sample Substances 0.000 description 20
- 238000011161 development Methods 0.000 description 17
- 230000018109 developmental process Effects 0.000 description 17
- 230000006870 function Effects 0.000 description 14
- 210000004556 brain Anatomy 0.000 description 13
- 238000002592 echocardiography Methods 0.000 description 13
- 230000001965 increasing effect Effects 0.000 description 13
- 230000004044 response Effects 0.000 description 13
- 206010012289 Dementia Diseases 0.000 description 12
- 208000024827 Alzheimer disease Diseases 0.000 description 11
- 208000026106 cerebrovascular disease Diseases 0.000 description 11
- 238000002597 diffusion-weighted imaging Methods 0.000 description 11
- 239000000126 substance Substances 0.000 description 11
- 238000002591 computed tomography Methods 0.000 description 10
- 238000013459 approach Methods 0.000 description 9
- 238000001574 biopsy Methods 0.000 description 9
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 230000000875 corresponding effect Effects 0.000 description 9
- 230000007423 decrease Effects 0.000 description 9
- 238000006073 displacement reaction Methods 0.000 description 9
- 238000002600 positron emission tomography Methods 0.000 description 8
- 230000008569 process Effects 0.000 description 8
- 238000002560 therapeutic procedure Methods 0.000 description 8
- 210000005166 vasculature Anatomy 0.000 description 8
- 239000013626 chemical specie Substances 0.000 description 7
- 238000012937 correction Methods 0.000 description 7
- 230000001419 dependent effect Effects 0.000 description 7
- 230000006872 improvement Effects 0.000 description 7
- 210000004185 liver Anatomy 0.000 description 7
- 238000001208 nuclear magnetic resonance pulse sequence Methods 0.000 description 7
- 238000012805 post-processing Methods 0.000 description 7
- 230000009467 reduction Effects 0.000 description 7
- 238000004088 simulation Methods 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 208000001132 Osteoporosis Diseases 0.000 description 6
- 230000037180 bone health Effects 0.000 description 6
- 208000019423 liver disease Diseases 0.000 description 6
- 230000005415 magnetization Effects 0.000 description 6
- 230000007246 mechanism Effects 0.000 description 6
- 201000006417 multiple sclerosis Diseases 0.000 description 6
- 230000001537 neural effect Effects 0.000 description 6
- 230000010363 phase shift Effects 0.000 description 6
- 230000035945 sensitivity Effects 0.000 description 6
- 230000002123 temporal effect Effects 0.000 description 6
- 208000010392 Bone Fractures Diseases 0.000 description 5
- 206010017076 Fracture Diseases 0.000 description 5
- 239000000654 additive Substances 0.000 description 5
- 230000000996 additive effect Effects 0.000 description 5
- 230000002411 adverse Effects 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 230000000747 cardiac effect Effects 0.000 description 5
- 230000015556 catabolic process Effects 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 208000019425 cirrhosis of liver Diseases 0.000 description 5
- 230000003247 decreasing effect Effects 0.000 description 5
- 238000006731 degradation reaction Methods 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 238000009547 dual-energy X-ray absorptiometry Methods 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 230000036039 immunity Effects 0.000 description 5
- 238000002372 labelling Methods 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 208000004051 Chronic Traumatic Encephalopathy Diseases 0.000 description 4
- 208000010859 Creutzfeldt-Jakob disease Diseases 0.000 description 4
- 206010061818 Disease progression Diseases 0.000 description 4
- 208000030886 Traumatic Brain injury Diseases 0.000 description 4
- 230000008901 benefit Effects 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 210000005013 brain tissue Anatomy 0.000 description 4
- 201000011510 cancer Diseases 0.000 description 4
- 230000003727 cerebral blood flow Effects 0.000 description 4
- 230000001054 cortical effect Effects 0.000 description 4
- 208000017004 dementia pugilistica Diseases 0.000 description 4
- 238000002598 diffusion tensor imaging Methods 0.000 description 4
- 230000005750 disease progression Effects 0.000 description 4
- 238000011156 evaluation Methods 0.000 description 4
- 230000009021 linear effect Effects 0.000 description 4
- 230000004807 localization Effects 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 230000005855 radiation Effects 0.000 description 4
- 230000003595 spectral effect Effects 0.000 description 4
- 230000009529 traumatic brain injury Effects 0.000 description 4
- 206010006187 Breast cancer Diseases 0.000 description 3
- 208000026310 Breast neoplasm Diseases 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- 206010028347 Muscle twitching Diseases 0.000 description 3
- 238000012879 PET imaging Methods 0.000 description 3
- 238000002441 X-ray diffraction Methods 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 239000012472 biological sample Substances 0.000 description 3
- 210000003710 cerebral cortex Anatomy 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- 230000000295 complement effect Effects 0.000 description 3
- 230000001010 compromised effect Effects 0.000 description 3
- 238000001514 detection method Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 210000003414 extremity Anatomy 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 238000006213 oxygenation reaction Methods 0.000 description 3
- 239000000700 radioactive tracer Substances 0.000 description 3
- 238000011160 research Methods 0.000 description 3
- 230000000241 respiratory effect Effects 0.000 description 3
- 239000011435 rock Substances 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- ZCXUVYAZINUVJD-AHXZWLDOSA-N 2-deoxy-2-((18)F)fluoro-alpha-D-glucose Chemical compound OC[C@H]1O[C@H](O)[C@H]([18F])[C@@H](O)[C@@H]1O ZCXUVYAZINUVJD-AHXZWLDOSA-N 0.000 description 2
- 208000037259 Amyloid Plaque Diseases 0.000 description 2
- 206010003805 Autism Diseases 0.000 description 2
- 208000020706 Autistic disease Diseases 0.000 description 2
- 206010016654 Fibrosis Diseases 0.000 description 2
- 230000002159 abnormal effect Effects 0.000 description 2
- 206010002026 amyotrophic lateral sclerosis Diseases 0.000 description 2
- 239000000090 biomarker Substances 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000009787 cardiac fibrosis Effects 0.000 description 2
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 210000003618 cortical neuron Anatomy 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000013399 early diagnosis Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000002599 functional magnetic resonance imaging Methods 0.000 description 2
- 230000004153 glucose metabolism Effects 0.000 description 2
- 210000004884 grey matter Anatomy 0.000 description 2
- 208000019622 heart disease Diseases 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 238000012317 liver biopsy Methods 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000010603 microCT Methods 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000002610 neuroimaging Methods 0.000 description 2
- 230000007171 neuropathology Effects 0.000 description 2
- 230000009022 nonlinear effect Effects 0.000 description 2
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 2
- 230000008520 organization Effects 0.000 description 2
- 230000010355 oscillation Effects 0.000 description 2
- 230000010412 perfusion Effects 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 230000000541 pulsatile effect Effects 0.000 description 2
- 238000000264 spin echo pulse sequence Methods 0.000 description 2
- 230000003068 static effect Effects 0.000 description 2
- 230000008685 targeting Effects 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000036962 time dependent Effects 0.000 description 2
- 230000004614 tumor growth Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 210000004885 white matter Anatomy 0.000 description 2
- 102000013455 Amyloid beta-Peptides Human genes 0.000 description 1
- 108010090849 Amyloid beta-Peptides Proteins 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 206010005949 Bone cancer Diseases 0.000 description 1
- 208000018084 Bone neoplasm Diseases 0.000 description 1
- 208000006154 Chronic hepatitis C Diseases 0.000 description 1
- 208000028698 Cognitive impairment Diseases 0.000 description 1
- 201000003883 Cystic fibrosis Diseases 0.000 description 1
- 206010067889 Dementia with Lewy bodies Diseases 0.000 description 1
- 208000000202 Diffuse Axonal Injury Diseases 0.000 description 1
- 102000001554 Hemoglobins Human genes 0.000 description 1
- 108010054147 Hemoglobins Proteins 0.000 description 1
- 208000005176 Hepatitis C Diseases 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 208000032382 Ischaemic stroke Diseases 0.000 description 1
- 201000002832 Lewy body dementia Diseases 0.000 description 1
- 208000019693 Lung disease Diseases 0.000 description 1
- 206010027476 Metastases Diseases 0.000 description 1
- 208000019430 Motor disease Diseases 0.000 description 1
- 238000012565 NMR experiment Methods 0.000 description 1
- 208000011623 Obstructive Lung disease Diseases 0.000 description 1
- 208000018737 Parkinson disease Diseases 0.000 description 1
- 206010060862 Prostate cancer Diseases 0.000 description 1
- 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
- 206010067362 Radiation necrosis Diseases 0.000 description 1
- 208000016247 Soft tissue disease Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 230000002491 angiogenic effect Effects 0.000 description 1
- 230000003466 anti-cipated effect Effects 0.000 description 1
- 238000003491 array Methods 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 210000003050 axon Anatomy 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000003542 behavioural effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000037182 bone density Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 230000037118 bone strength Effects 0.000 description 1
- 230000003925 brain function Effects 0.000 description 1
- 208000029028 brain injury Diseases 0.000 description 1
- 230000010351 cardiac pulsation Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000007882 cirrhosis Effects 0.000 description 1
- 230000003930 cognitive ability Effects 0.000 description 1
- 230000006999 cognitive decline Effects 0.000 description 1
- 208000010877 cognitive disease Diseases 0.000 description 1
- 230000001427 coherent effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 239000002872 contrast media Substances 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 210000005257 cortical tissue Anatomy 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 125000004122 cyclic group Chemical group 0.000 description 1
- 238000013480 data collection Methods 0.000 description 1
- 238000005034 decoration Methods 0.000 description 1
- 238000000326 densiometry Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000002405 diagnostic procedure Methods 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 238000003748 differential diagnosis Methods 0.000 description 1
- 230000009521 diffuse axonal injury Effects 0.000 description 1
- 238000002091 elastography Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 208000020089 femoral neck fracture Diseases 0.000 description 1
- 230000004761 fibrosis Effects 0.000 description 1
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 1
- 210000004326 gyrus cinguli Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000010710 hepatitis C virus infection Diseases 0.000 description 1
- 238000003709 image segmentation Methods 0.000 description 1
- 238000011503 in vivo imaging Methods 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000011528 liquid biopsy Methods 0.000 description 1
- 238000012045 magnetic resonance elastography Methods 0.000 description 1
- 210000005075 mammary gland Anatomy 0.000 description 1
- 238000007620 mathematical function Methods 0.000 description 1
- 238000012067 mathematical method Methods 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 210000004088 microvessel Anatomy 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000009456 molecular mechanism Effects 0.000 description 1
- 201000006938 muscular dystrophy Diseases 0.000 description 1
- 206010028537 myelofibrosis Diseases 0.000 description 1
- 230000004770 neurodegeneration Effects 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 238000012856 packing Methods 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 208000005069 pulmonary fibrosis Diseases 0.000 description 1
- 238000011002 quantification Methods 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 206010041569 spinal fracture Diseases 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 230000000153 supplemental effect Effects 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 230000008354 tissue degradation Effects 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 230000005748 tumor development Effects 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 238000012285 ultrasound imaging Methods 0.000 description 1
- 208000026533 urinary bladder disease Diseases 0.000 description 1
- 238000012795 verification Methods 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/4818—MR characterised by data acquisition along a specific k-space trajectory or by the temporal order of k-space coverage, e.g. centric or segmented coverage of k-space
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
- A61B5/055—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves involving electronic [EMR] or nuclear [NMR] magnetic resonance, e.g. magnetic resonance imaging
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/72—Signal processing specially adapted for physiological signals or for diagnostic purposes
- A61B5/7203—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal
- A61B5/7207—Signal processing specially adapted for physiological signals or for diagnostic purposes for noise prevention, reduction or removal of noise induced by motion artifacts
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/28—Details of apparatus provided for in groups G01R33/44 - G01R33/64
- G01R33/38—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field
- G01R33/385—Systems for generation, homogenisation or stabilisation of the main or gradient magnetic field using gradient magnetic field coils
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/483—NMR imaging systems with selection of signals or spectra from particular regions of the volume, e.g. in vivo spectroscopy
- G01R33/4833—NMR imaging systems with selection of signals or spectra from particular regions of the volume, e.g. in vivo spectroscopy using spatially selective excitation of the volume of interest, e.g. selecting non-orthogonal or inclined slices
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/561—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution by reduction of the scanning time, i.e. fast acquiring systems, e.g. using echo-planar pulse sequences
- G01R33/5615—Echo train techniques involving acquiring plural, differently encoded, echo signals after one RF excitation, e.g. using gradient refocusing in echo planar imaging [EPI], RF refocusing in rapid acquisition with relaxation enhancement [RARE] or using both RF and gradient refocusing in gradient and spin echo imaging [GRASE]
- G01R33/5616—Echo train techniques involving acquiring plural, differently encoded, echo signals after one RF excitation, e.g. using gradient refocusing in echo planar imaging [EPI], RF refocusing in rapid acquisition with relaxation enhancement [RARE] or using both RF and gradient refocusing in gradient and spin echo imaging [GRASE] using gradient refocusing, e.g. EPI
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
- G01R33/00—Arrangements or instruments for measuring magnetic variables
- G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
- G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
- G01R33/48—NMR imaging systems
- G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
- G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
- G01R33/561—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution by reduction of the scanning time, i.e. fast acquiring systems, e.g. using echo-planar pulse sequences
- G01R33/5615—Echo train techniques involving acquiring plural, differently encoded, echo signals after one RF excitation, e.g. using gradient refocusing in echo planar imaging [EPI], RF refocusing in rapid acquisition with relaxation enhancement [RARE] or using both RF and gradient refocusing in gradient and spin echo imaging [GRASE]
- G01R33/5617—Echo train techniques involving acquiring plural, differently encoded, echo signals after one RF excitation, e.g. using gradient refocusing in echo planar imaging [EPI], RF refocusing in rapid acquisition with relaxation enhancement [RARE] or using both RF and gradient refocusing in gradient and spin echo imaging [GRASE] using RF refocusing, e.g. RARE
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- High Energy & Nuclear Physics (AREA)
- Condensed Matter Physics & Semiconductors (AREA)
- General Physics & Mathematics (AREA)
- Signal Processing (AREA)
- Biophysics (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Surgery (AREA)
- Pathology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Artificial Intelligence (AREA)
- Psychiatry (AREA)
- Physiology (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Radiology & Medical Imaging (AREA)
- Optics & Photonics (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Magnetic Resonance Imaging Apparatus (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462044321P | 2014-09-01 | 2014-09-01 | |
| US62/044,321 | 2014-09-01 | ||
| US201462064206P | 2014-10-15 | 2014-10-15 | |
| US62/064,206 | 2014-10-15 | ||
| US201562107465P | 2015-01-25 | 2015-01-25 | |
| US62/107,465 | 2015-01-25 | ||
| PCT/US2015/047676 WO2016036643A1 (en) | 2014-09-01 | 2015-08-31 | Selective sampling magnetic resonance-based method for assessing structural spatial frequencies |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA2959621A1 true CA2959621A1 (en) | 2016-03-10 |
Family
ID=55402215
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA2959621A Pending CA2959621A1 (en) | 2014-09-01 | 2015-08-31 | Selective sampling magnetic resonance-based method for assessing structural spatial frequencies |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US9366738B2 (enExample) |
| EP (1) | EP3189345A4 (enExample) |
| JP (1) | JP6553723B2 (enExample) |
| CN (1) | CN106716167B (enExample) |
| AU (2) | AU2015312190A1 (enExample) |
| CA (1) | CA2959621A1 (enExample) |
| WO (1) | WO2016036643A1 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6362950B2 (ja) * | 2014-07-24 | 2018-07-25 | ジーイー・メディカル・システムズ・グローバル・テクノロジー・カンパニー・エルエルシー | 磁気共鳴装置 |
| US10955503B2 (en) * | 2014-09-01 | 2021-03-23 | Bioprotonics, Inc. | Method to measure tissue texture using NMR spectroscopy with VOI length in an analysis direction defined by receiver bandwidth |
| US10061003B2 (en) * | 2014-09-01 | 2018-08-28 | bioProtonics, L.L.C. | Selective sampling for assessing structural spatial frequencies with specific contrast mechanisms |
| US9664760B2 (en) * | 2014-09-01 | 2017-05-30 | bioProtonics, L.L.C | Selective sampling for assessing structural spatial frequencies with specific contrast mechanisms |
| US10215827B2 (en) * | 2014-09-01 | 2019-02-26 | Bioprotonics Inc. | Method to measure tissue texture using NMR spectroscopy to identify the chemical species of component textural elements in a targeted region of tissue |
| US10085703B2 (en) * | 2015-01-27 | 2018-10-02 | Septimiu Edmund Salcudean | Dynamic computed tomography imaging of elasticity |
| GB201505940D0 (en) | 2015-04-08 | 2015-05-20 | Isis Innovation | Medical imaging |
| KR102449249B1 (ko) * | 2015-05-27 | 2022-09-30 | 삼성전자주식회사 | 자기 공명 영상 장치 및 그 방법 |
| CN108366753B (zh) * | 2015-10-07 | 2019-06-07 | 生物质子股份有限公司 | 用于评估具有指定对比度机制的结构空间频率的选择性采样 |
| CN110958854A (zh) * | 2017-05-24 | 2020-04-03 | 生物质子股份有限公司 | 用于评估具有指定对比度机制的结构空间频率的选择性采样 |
| DE102017210700A1 (de) * | 2017-06-26 | 2018-12-27 | Robert Bosch Gmbh | Verfahren zum automatisierten Quantifizieren eines Analyten sowie NMR-Messgerät zur Durchführung des Verfahrens |
| WO2019010381A1 (en) * | 2017-07-06 | 2019-01-10 | bioProtonics, LLC | METHOD FOR MEASURING TISSUE TEXTURE USING NMR SPECTROSCOPY TO IDENTIFY CHEMICAL SPECIES OF COMPONENT TEXTURE ELEMENTS IN TARGETED TISSUE REGION |
| EP3517988A1 (en) * | 2018-01-29 | 2019-07-31 | Koninklijke Philips N.V. | Mr imaging using a stack-of-stars acquisition with intrinsic motion correction |
| US10585154B1 (en) * | 2018-01-29 | 2020-03-10 | Quantum Valley Investment Fund LP | Nuclear magnetic resonance diffraction |
| US10775466B2 (en) * | 2018-02-09 | 2020-09-15 | GE Precision Healthcare LLC | System and method for magnetic resonance imaging an object via a stochastic optimization of a sampling function |
| EP3550319A1 (en) * | 2018-04-05 | 2019-10-09 | Koninklijke Philips N.V. | Emulation mode for mri |
| CN108919355B (zh) * | 2018-05-14 | 2020-04-07 | 中国海洋石油集团有限公司 | 基于结构张量导引的高维s变换方法 |
| JP7220727B2 (ja) | 2019-01-31 | 2023-02-10 | 富士フイルム株式会社 | 学習済みモデル、学習方法、及びプログラム、並びに医用情報取得装置、方法、及びプログラム |
| CN112415452B (zh) * | 2019-08-22 | 2024-03-19 | 西门子(深圳)磁共振有限公司 | 去除信号中干扰的方法和装置、磁共振系统和存储介质 |
| US12423807B2 (en) * | 2020-02-03 | 2025-09-23 | Koninklijke Philips N.V. | Apparatus to analyse diffusion magnetic resonance imaging data |
| CN111861236B (zh) * | 2020-07-27 | 2023-10-27 | 东北大学 | 一种棒材精整工艺数据同步方法 |
| US12136217B2 (en) * | 2021-01-18 | 2024-11-05 | Bioprotonics, Inc. | Magnetic-resonance-based method for measuring microscopic histologic soft tissue textures |
| CN113156350B (zh) * | 2021-03-25 | 2022-07-19 | 华南理工大学 | 无创光不透明微米级活体组织磁共振断层成像方法及系统 |
| JP2024517761A (ja) * | 2021-04-30 | 2024-04-23 | リージェンツ オブ ザ ユニバーシティ オブ ミネソタ | 磁気共鳴映像法における無線周波数（ｒｆ）ベースの空間符号化のためのシステム及び方法 |
| CN113671427B (zh) * | 2021-08-24 | 2022-07-15 | 上海交通大学 | 磁共振弹性成像位移采集方法及系统 |
| US12372595B2 (en) | 2022-04-21 | 2025-07-29 | Regents Of The University Of Minnesota | Multi-echo radio frequency (RF) based spatial encoding in magnetic resonance imaging using frequency-modulated RF pulses |
| CN119827549B (zh) * | 2023-10-12 | 2025-09-23 | 无锡鸣石峻致医疗科技有限公司 | 一种具备空间选择性的岩样测量系统及测量方法 |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4471306A (en) * | 1982-02-03 | 1984-09-11 | General Electric Company | Method of NMR imaging which overcomes T2 * effects in an inhomogeneous static magnetic field |
| JPS60146138A (ja) * | 1984-01-11 | 1985-08-01 | Hitachi Ltd | 核磁気共鳴を用いた検査装置 |
| IL78240A (en) * | 1986-03-24 | 1989-09-10 | Elscint Ltd | Spatially localized spectroscopy |
| JPS63130056A (ja) * | 1986-11-21 | 1988-06-02 | 旭化成株式会社 | 部分選択核磁気共鳴情報導出方法 |
| JP3393895B2 (ja) * | 1993-09-13 | 2003-04-07 | 株式会社東芝 | 磁気共鳴映像装置 |
| US6134464A (en) * | 1997-09-19 | 2000-10-17 | General Electric Company | Multi-slice and multi-angle MRI using fast spin echo acquisition |
| AU2001280429A1 (en) * | 2000-04-26 | 2001-11-12 | Mayo Foundation For Medical Education And Research | Reduction of motion artifact in nmr images using spherical navigator signals |
| US7057388B2 (en) * | 2002-11-18 | 2006-06-06 | Koninklijke Philips Electronics N.V. | Magnetic resonance method and device |
| US7916144B2 (en) * | 2005-07-13 | 2011-03-29 | Siemens Medical Solutions Usa, Inc. | High speed image reconstruction for k-space trajectory data using graphic processing unit (GPU) |
| US7218110B2 (en) * | 2005-09-02 | 2007-05-15 | Toshiba America Mri, Inc. | Method and apparatus for diffusion magnetic resonance imaging with the effects of eddy currents compensated |
| KR101297143B1 (ko) | 2005-11-27 | 2013-08-21 | 아쿠이타스 메디컬 리미티드 | 공간 주파수 분석을 이용한 뼈와 같은 구조의 평가 |
| US7903251B1 (en) | 2009-02-20 | 2011-03-08 | Acuitas Medical Limited | Representation of spatial-frequency data as a map |
| DE102011007501B3 (de) * | 2011-04-15 | 2012-05-31 | Universitätsklinikum Freiburg | Verfahren der bildgebenden Magnetresonanz zur Selektion und Aufnahme von gekrümmten Schichten |
| WO2013040086A1 (en) * | 2011-09-13 | 2013-03-21 | Acuitas Medical Limited | Magnetic resonance based method for assessing alzheimer's disease and related pathologies |
| EP2760337A2 (en) | 2011-09-26 | 2014-08-06 | Acuitas Medical Limited | Method for detection of characteristics of organ fibrosis |
| US9360542B2 (en) * | 2012-04-20 | 2016-06-07 | Wisconsin Alumni Research Foundation | System and method for spectrally-resolved three-dimensional magnetic resonance imaging without frequency-encoding gradients |
-
2015
- 2015-08-31 CA CA2959621A patent/CA2959621A1/en active Pending
- 2015-08-31 WO PCT/US2015/047676 patent/WO2016036643A1/en not_active Ceased
- 2015-08-31 CN CN201580053403.5A patent/CN106716167B/zh active Active
- 2015-08-31 US US14/840,327 patent/US9366738B2/en active Active
- 2015-08-31 AU AU2015312190A patent/AU2015312190A1/en not_active Abandoned
- 2015-08-31 EP EP15837428.0A patent/EP3189345A4/en not_active Withdrawn
- 2015-08-31 JP JP2017530978A patent/JP6553723B2/ja active Active
-
2021
- 2021-03-31 AU AU2021201998A patent/AU2021201998B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3189345A1 (en) | 2017-07-12 |
| AU2015312190A1 (en) | 2017-03-23 |
| US20160061917A1 (en) | 2016-03-03 |
| WO2016036643A1 (en) | 2016-03-10 |
| AU2021201998B2 (en) | 2023-01-12 |
| JP6553723B2 (ja) | 2019-07-31 |
| EP3189345A4 (en) | 2018-05-09 |
| AU2021201998A1 (en) | 2021-04-29 |
| CN106716167A (zh) | 2017-05-24 |
| US9366738B2 (en) | 2016-06-14 |
| JP2017526505A (ja) | 2017-09-14 |
| CN106716167B (zh) | 2019-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2021201998B2 (en) | Selective sampling magnetic resonance-based method for assessing structural spatial frequencies | |
| CA3000765C (en) | Selective sampling for assessing structural spatial frequencies with specific contrast mechanisms | |
| US9664760B2 (en) | Selective sampling for assessing structural spatial frequencies with specific contrast mechanisms | |
| US11175363B2 (en) | Selective sampling for assessing structural spatial frequencies with specific contrast mechanisms | |
| US9664759B2 (en) | Method for assessing structural spatial frequencies using hybrid sampling with non-zero gradient for enhancement of selective sampling | |
| Mueller et al. | Dual-source radiofrequency transmission with patient-adaptive local radiofrequency shimming for 3.0-T cardiac MR imaging: initial experience | |
| Vargas et al. | Clinical neuroimaging using 7 T MRI: challenges and prospects | |
| WO2018217658A1 (en) | Selective sampling for assessing structural spatial frequencies with specific contrast mechanisms | |
| WO2013116775A1 (en) | System and method for image processing with highly undersampled imaging data | |
| Liney | MRI from A to Z: a definitive guide for medical professionals | |
| Li et al. | Multi‐parametric MRI for radiotherapy simulation | |
| Bihan-Poudec et al. | Cardiovascular effects on high-resolution 3D multi-shot diffusion MRI of the rhesus macaque brain | |
| Stachera et al. | Heart and Brain in Magnetic Resonance Imaging | |
| Sammet | Magnetic Resonance Imaging (MRI) | |
| Yun et al. | Selective Applications of MRI for the Brain | |
| Jackson | Technical progress in neuroradiology and its application | |
| Weis et al. | Imaging Modalities: Neuroradiology | |
| Papanastasiou | Quantification of cardiac magnetic resonance imaging perfusion in the clinical setting at 3T | |
| Karatopis et al. | Molecular imaging of the myoskeletal system through Diffusion Weighted and Diffusion Tensor Imaging with parallel imaging techniques |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EEER | Examination request |
Effective date: 20200820 |
|
| EEER | Examination request |
Effective date: 20200820 |
|
| EEER | Examination request |
Effective date: 20200820 |
|
| EEER | Examination request |
Effective date: 20200820 |
|
| EEER | Examination request |
Effective date: 20200820 |
|
| EEER | Examination request |
Effective date: 20200820 |
|
| EEER | Examination request |
Effective date: 20200820 |